Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention: a meta-analysis.

Introduction: The ideal duration of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) is still unknown. In this meta-analysis, we aimed to compare very short-term (1-3 months), short-term (6 months), standard-term (12 months) and long-term (>12 months) DAPT durations for efficacy and safety.

Methods: Overall DAPT comparisons were classified as "any shorter-term"/"any longer-term" DAPT.